Grants and Contributions:

Back to search

Title:

E!7335 INCANT: Innovative Characterization of Nanoparticle drug delivery systems for next-generation Therapeutics

Agreement Number:

1035119

Agreement Value:

$249,900.00

Agreement Date:

Oct 1, 2025 - Mar 24, 2028

Description:

This project completes the development of the iLoF system for profiling Lipid Nanoparticles (LNPs) and Extracellular Vesicles (EVs), with the goal of bringing it to market. The frim is contributing by optimizing characterization methods, producing various LNP formulations, and testing the system on site.

Organization:

National Research Council Canada

Expected Results:

The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization

Location:

Montreal, Quebec, CA H2W 1R7

Reference Number:

172-2025-2026-Q3-1035119

Agreement Type:

Contribution

Report Type:

Grants and Contributions

Recipient Business Number:

714255304

Recipient Type:

For-profit organization

Recipient's Operating Name:

ARN Technologies & Thérapeutiques

Recipient's Legal Name:

RNA Technologies & Therapeutics (RNA T&T) inc.

Federal Riding Name:

Laurier--Sainte-Marie

Federal Riding Number:

24039

Program:

Industrial Research Assistance Program – Contributions to Firms

Program Purpose:

Coverage:

IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.

NAICS Code:

325410